Transient Ischemic Attack News and Research

RSS

A transient ischemic attack (TIA) is a transient stroke that lasts only a few minutes. It occurs when the blood supply to part of the brain is briefly interrupted. TIA symptoms, which usually occur suddenly, are similar to those of stroke but do not last as long. Most symptoms of a TIA disappear within an hour, although they may persist for up to 24 hours. Symptoms can include: numbness or weakness in the face, arm, or leg, especially on one side of the body; confusion or difficulty in talking or understanding speech; trouble seeing in one or both eyes; and difficulty with walking, dizziness, or loss of balance and coordination.

Secondary analysis reinforces safety of blood thinner

Treatment with the blood thinner apixaban was associated with a lower risk of bleeding, death and hospitalization compared with warfarin, regardless of history of prior stroke or blood clot, according to a secondary analysis presented as late breaking science today at the American Stroke Association's International Stroke Conference 2020.

23 Feb 2020

Spikes in blood pressure among young adults linked to higher risk of heart disease by middle age

Wide swings in blood pressure readings among young adults are associated with a higher risk of cardiovascular disease by middle age, a new analysis led by Duke Health researchers shows.

22 Jan 2020

Young adults with PTSD more likely to experience a stroke event by middle age

Young adults who suffer from posttraumatic stress disorder may be more likely to experience a transient ischemic attack or major stroke event by middle age, raising the risk as much as other better-known risk factors, according to new research published in Stroke, a journal of the American Stroke Association, a division of the American Heart Association.

17 Oct 2019

Study: Revascularization with PCI or CABG prolongs survival in patients with left main disease

Patients with left main coronary artery disease (LMCAD) typically have a poor prognosis due to the large amount of myocardium at risk.

30 Sep 2019

Metformin for diabetics with renal damage scores over Sulphonylureas in terms of heart safety

There are several drugs that are being used for treatment of type 2 diabetes. Many type 2 diabetics suffer from kidney disorders that are caused by persistent high levels of blood sugar.

25 Sep 2019

Study shows metformin is safe for patients with mild-to- moderate kidney disease

Over the years, there has been uncertainty over which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease.

25 Sep 2019

Study highlights importance of MRI in helping diagnose minor strokes

A University of Calgary-led international study is highlighting the importance of magnetic resonance imaging in helping to diagnose minor stroke and transient ischemic attacks.

23 Sep 2019

Exposure to 9/11 WTC dust associated with increased risk of heart disease in NYC firefighters

A new study of New York City firefighters has found that exposure to 9/11 World Trade Center dust is associated with a significantly increased long-term risk of cardiovascular disease.

7 Sep 2019

Study investigates association between migraine diagnoses and dementia

Several studies have recently focused on the association between migraine headaches and other headaches and dementia and found a positive migraine-dementia relationship.

14 Aug 2019

Testosterone replacement therapy associated with increased risk of stroke, heart attack

Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.

18 Jul 2019

More than 936 million people have sleep apnea, ResMed-led analysis reveals

More than 936 million people have obstructive sleep apnea – the disease’s first prevalence update in more than a decade – according to The Lancet Respiratory Medicine, the world’s leading journal in its field.

10 Jul 2019

Antihypertensive drug use linked with reduction in dementia risk

Various clinical trials indicate what effects can be expected from standardized intervention programs on the basis of existing evidence.

3 Jun 2019

Women experiencing minor stroke are less likely to be diagnosed than men

Women experiencing a minor stroke or transient ischemic attack (TIA) are less likely to be diagnosed with a stroke compared to men -- even though they describe similar symptoms in emergency departments.

23 May 2019

Study sheds light on link between higher BMI and serious health outcomes, death

A new study has shed light on the link between higher body mass index and serious health outcomes and death in over 2.8 million adults representative of the UK population.

29 Apr 2019

Rheumatoid arthritis patients likely to experience cardiovascular benefits from statins

Results from a large clinical trial indicate that patients with rheumatoid arthritis are likely to experience the same level of cardiovascular benefits from statins as other individuals, without additional risks.

15 Apr 2019

Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack

Patients given clot busters to treat a heart attack fared equally well if they were given the standard blood thinning medication clopidogrel versus the newer, more potent drug ticagrelor, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session.

19 Mar 2019

Specific beliefs of stroke survivors have the power to lower blood pressure

Stroke survivors who believe they can protect themselves from having another stroke had more than twice the blood pressure reduction of nonbelievers, according to preliminary research to be presented in Honolulu at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.

30 Jan 2019

Study highlights need for reliable therapeutic targets for prevention, treatment of cardiovascular diseases

CVD (cardiovascular diseases) are proven to be the leading cause of deaths throughout the world. If statistics are reviewed, almost four out of five deaths are due to myocardial infarction or stroke.

21 Jan 2019

UC researchers receive $3.2 million grant to study stroke recurrence risk

Researchers at the University of Cincinnati have received a $3.2 million grant from the National Institute of Neurological Diseases to study the use of neuroimaging to pinpoint the risk factors of stroke recurrence.

7 Jan 2019

Using untargeted metabolomics to find biomarkers and therapeutic targets for CVD

Cardiovascular diseases are proven to be the leading cause of deaths throughout the world. If statistics are reviewed, almost four out of five deaths are due to myocardial infarction or stroke. Efforts to prevent CVD have little effect on the decrease of the number of CVD related deaths despite many medical advances.

26 Dec 2018